2025-01-16 10:02:53
ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.
Corporate/ 2023-07-23
ArcScan, Inc. Signs Definitive Agreement...

GOLDEN,Colo.,July 21,2021--ArcScan,Inc.,the developer of state-of-the-art ophthalmic ultrasound imaging device "ArcScan Insight® 10...

AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA
Health/ 2023-07-22
AnchorDx's Non-invasive Bladder Can...

GUANGZHOU,China,July 21,2021-- AnchorDx,a world-leading developer of cancer screening and early detection solutions,on July 13,2021,was awar...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release